Results 271 to 280 of about 74,461 (380)
Herein, a liver‐targeted nanohybrid formulation, SGLC/DOX@AG, is developed to enhance doxorubicin delivery and reduce vascular toxicity in hepatocellular carcinoma (HCC) treatment. Incorporating an albumin–glucosamine lipid complex, the system shows potent anticancer effects and minimized side effects across in vitro, in vivo, and cancer‐on‐a‐chip ...
Hyelim Kim+11 more
wiley +1 more source
Assessing the Causal Relationships Between Lipid Species and Stroke by Using Mendelian Randomization. [PDF]
Wang SQ+5 more
europepmc +1 more source
Emerging Nanonutraceuticals against Obesity
This overview comprehensively compiles the latest research advancements in diversiform nanonutraceuticals against obesity. These nanonutraceuticals are derived from the nanomodifications of some carbohydrates, lipids, proteins, vitamins, minerals, and phytochemicals.
Linjie Ni+8 more
wiley +1 more source
A network-based approach to discover diagnostic metabolite markers associated with depressive features for major depressive disorder. [PDF]
Zheng Y+5 more
europepmc +1 more source
Coronary artery disease risk and lipidomic profiles are similar in hyperlipidemias with family history and population-ascertained hyperlipidemias [PDF]
et al,, Stitziel, Nathan O
core +1 more source
The interactions between colloidal structures in intestinal fluids and therapeutics, nanoparticles, and polymers are investigated. By designing different simulated intestinal fluids, reveal how the concentration and type of bile salts and lipids affect drug solubility, nanoparticle aggregation and cytotoxicity, as well as mucoadhesion of nanoparticles ...
Juliane Fjelrad Christfort+5 more
wiley +1 more source
Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers
Oral delivery is a preferred administration route for many clinical applications, valued for its strong patient compliance. In this review, how nanoparticles are engineered and deployed to overcome the gastrointestinal barriers that impede clinical translation of oral delivery formulations is examined.
Luke J. Kubiatowicz+5 more
wiley +1 more source